Nonpharmacologic treatment of hypertension.

Norman M Kaplan

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A variety of lifestyle modifications will lower both the blood pressure and various other cardiovascular risk factors that are frequently present in patients with hypertension. Numerous recent studies document the overall efficacy of some (weight reduction, sodium restriction, physical activity, moderation of alcohol) and the relative lack of effect of others (stress management and calcium, magnesium, and fish oil supplements). In particular, the Trials of Hypertension Prevention, Phase I (a control trial funded by the National Heart, Lung, and Blood Institute) provides important new data on the ability of these various modalities to prevent the development of hypertension, an equally or even more important goal than the reduction of already-established disease.

Original languageEnglish (US)
Pages (from-to)85-90
Number of pages6
JournalCurrent Opinion in Nephrology and Hypertension
Volume1
Issue number1
StatePublished - Oct 1992

Fingerprint

Hypertension
National Heart, Lung, and Blood Institute (U.S.)
Aptitude
Fish Oils
Magnesium
Life Style
Weight Loss
Therapeutics
Sodium
Alcohols
Exercise
Blood Pressure
Calcium

ASJC Scopus subject areas

  • Internal Medicine
  • Nephrology

Cite this

Nonpharmacologic treatment of hypertension. / Kaplan, Norman M.

In: Current Opinion in Nephrology and Hypertension, Vol. 1, No. 1, 10.1992, p. 85-90.

Research output: Contribution to journalArticle

@article{549bd350c7f64416b6cd7e4772628a69,
title = "Nonpharmacologic treatment of hypertension.",
abstract = "A variety of lifestyle modifications will lower both the blood pressure and various other cardiovascular risk factors that are frequently present in patients with hypertension. Numerous recent studies document the overall efficacy of some (weight reduction, sodium restriction, physical activity, moderation of alcohol) and the relative lack of effect of others (stress management and calcium, magnesium, and fish oil supplements). In particular, the Trials of Hypertension Prevention, Phase I (a control trial funded by the National Heart, Lung, and Blood Institute) provides important new data on the ability of these various modalities to prevent the development of hypertension, an equally or even more important goal than the reduction of already-established disease.",
author = "Kaplan, {Norman M}",
year = "1992",
month = "10",
language = "English (US)",
volume = "1",
pages = "85--90",
journal = "Current Opinion in Nephrology and Hypertension",
issn = "1062-4821",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Nonpharmacologic treatment of hypertension.

AU - Kaplan, Norman M

PY - 1992/10

Y1 - 1992/10

N2 - A variety of lifestyle modifications will lower both the blood pressure and various other cardiovascular risk factors that are frequently present in patients with hypertension. Numerous recent studies document the overall efficacy of some (weight reduction, sodium restriction, physical activity, moderation of alcohol) and the relative lack of effect of others (stress management and calcium, magnesium, and fish oil supplements). In particular, the Trials of Hypertension Prevention, Phase I (a control trial funded by the National Heart, Lung, and Blood Institute) provides important new data on the ability of these various modalities to prevent the development of hypertension, an equally or even more important goal than the reduction of already-established disease.

AB - A variety of lifestyle modifications will lower both the blood pressure and various other cardiovascular risk factors that are frequently present in patients with hypertension. Numerous recent studies document the overall efficacy of some (weight reduction, sodium restriction, physical activity, moderation of alcohol) and the relative lack of effect of others (stress management and calcium, magnesium, and fish oil supplements). In particular, the Trials of Hypertension Prevention, Phase I (a control trial funded by the National Heart, Lung, and Blood Institute) provides important new data on the ability of these various modalities to prevent the development of hypertension, an equally or even more important goal than the reduction of already-established disease.

UR - http://www.scopus.com/inward/record.url?scp=0026942315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026942315&partnerID=8YFLogxK

M3 - Article

C2 - 1365835

AN - SCOPUS:0026942315

VL - 1

SP - 85

EP - 90

JO - Current Opinion in Nephrology and Hypertension

JF - Current Opinion in Nephrology and Hypertension

SN - 1062-4821

IS - 1

ER -